Cardiovascular Effects of Metformin
Type 2 diabetes mellitus is one of the most important independent risk factors for the development, progression and mortality from cardiovascular diseases (CVD). The world communities are faced with the question of developing the optimal management tactics for such comorbidity patients. Thus, the pr...
Saved in:
| Main Authors: | B. T. Kurmanbekova, A. M. Noruizbaeva |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2022-03-01
|
| Series: | Рациональная фармакотерапия в кардиологии |
| Subjects: | |
| Online Access: | https://www.rpcardio.online/jour/article/view/2664 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Combined effects of metformin and coenzyme Q10 on doxorubicin-induced cardiotoxicity in male wistar rats
by: Faraz Mahdizadeh, et al.
Published: (2025-07-01) -
Bioactive Compounds, Their Mechanisms of Action, and Cardioprotective Effects of Pomegranate (Punica granatum): A Comprehensive Review
by: Esha Saeed, et al.
Published: (2025-08-01) -
Medication time of metformin and sulfonylureas and incidence of cardiovascular diseases and mortality in type 2 diabetes: a pooled cohort analysis
by: Mansour Bahardoust, et al.
Published: (2025-03-01) -
Metformin and cancer mortality
by: Lev Mikhaylovich Bershteyn
Published: (2010-09-01) -
Cardioprotective measures in patients with cardiovascular risk factors and polymorbidity
by: article Editorial
Published: (2022-10-01)